Skip to Main Navigation
Skip to Page Content
COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/10203

Primidone (primaclone): Target Organs and Levels of Evidence for TR-476

Toxicology and Carcinogenesis Studies of Primidone (CASRN 125-33-7) in F344/N Rats and B6C3F1 Mice (Feed Studies)

Chemical (Study Title)
CASRN		Peer Review DateRoute/Exposure LevelsStudy Laboratory
Primidone (primaclone)
125-33-7		12/12/1996Dosed-Feed
M: 0, 0.03, 0.06, OR 0.13% R: 0, 0.06, 0.13, OR 0.25% (50/SEX/SPECIES)		Battelle Columbus Laboratory

Levels of Evidence

Male Rats: Equivocal Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Thyroid Gland Follicular Cell: ADENOMA 1/50 1/50 6/49 3/49 OR CARCINOMA 1/50 3/50 1/49 1/49 COMBINED 2/50 4/50 7/49 4/49
  • Kidney Tubular Cell: (SINGLE SECTIONS) ADENOMA 2/50 1/50 1/50 1/50 OR CARCINOMA 0/50 0/50 0/50 1/50 COMBINED 2/50 1/50 1/50 2/50; (SINGLE AND STEP SECTIONS) ADENOMA 4/50 2/50 4/50 6/50 OR CARCINOMA 0/50 0/50 0/50 1/50 COMBINED 4/50 2/50 4/50 7/50
Non-Neoplastic Lesions
  • LIVER: CYTOPLASMIC VACUOLIZATION; CENTRILOBULAR HYPERTROPHY
  • KIDNEY: INCREASED SEVERITY OF NEPHROPATHY; RENAL TUBULE HYPERPLASIA
Female Rats: No Evidence
TypeOrgan/Tissue (Lesion)
Non-Neoplastic Lesions
  • LIVER: CYTOPLASMIC VACUOLIZATION; CENTRILOBULAR HYPERTROPHY; EOSINOPHILIC FOCUS
Male Mice: Clear Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Liver: ADENOMA 22/50 41/50 39/50 32/50, CARCINOMA 12/50 31/50 35/50 38/50 OR HEPATOBLASTOMA 0/50 17/50 26/50 7/50 COMBINED 31/50 49/50 49/50 46/50
  • Thyroid Gland Follicular Cell: ADENOMA 0/49 3/48 3/50 6/50
Non-Neoplastic Lesions
  • LIVER: CENTRILOBULAR HYPERTROPHY
  • THYROID GLAND: FOLLICULAR CELL HYPERPLASIA
Female Mice: Clear Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Liver: ADENOMA 15/50 42/50 45/49 47/50, CARCINOMA 3/50 11/50 19/49 38/50 OR HEPATOBLASTOMA 1/50 4/50 4/49 4/50 COMBINED 16/50 42/50 46/49 50/50
Non-Neoplastic Lesions
  • LIVER: CENTRILOBULAR HYPERTROPHY; CYTOPLASMIC VACUOLIZATION; EOSINOPHILIC FOCUS
  • THYROID GLAND: FOLLICULAR CELL HYPERPLASIA